Print

Print


Brain protein can boost war on Parkinson's
By Leslie Papp (Toronto Star)

Toronto researchers sponsering a potential breakthrough in Parkinson's
disease are installing a metal "bubble" under ths scalp of patients to
feed their brains a new protein.

"This is a very exciting project",said Dr Lang, director of the
Toronto Hospital's movement disorders clinic.
"This is the first attempt, in Parkinson's disease, to actually cause
some form of regeneration-to encourage growth of cells. This was not
possible before".

The hospital is one o six centers across North America involved in a
study testing the safety ...unreadable... new drug, designed to boost
the .... production of dopamine, a chemical required for brain cells
to exchange messages.

For some unknown reason .......unreadable ........ symptoms such as
tremors, muscle rigidity, balance problems and difficulty walking.

Most existing treatment try to ease those symptoms by replacing
missing chemicals in the brain.
The system being tested delivers a recently discovered protein to the
brain using a titanium bubble resting on the skull just under the
scalp.

About the diameter of a quarter and as thick as three such coins, the
bubble is connected to a catheter, or tube, to a fluid chamber deep
in the brain. This reservoir gradually releases the protein, called
G.D.N.F. (Can't make out the full name)

This material appears to increase the survival and growth of the
brain's dopamine - producing cells.

"It encourages cells that are sick, but not dead, to recover", Said
Dr Lang, prof of neurology at the University of Toronto. The supply of
protein held in the reservoir is recharged once a month.

Five Metro-area patients with advanced Parkinson's disease have so
far been treated. Another two have been fitted with the bubble system
and are awaiting injections of the drug.

Fifty people are to be treated at the six centers, part of a trial
with half receiving GDNF, and half getting a placebo, with no active
medical ingredient, for six months. After that, patients on the
placebl also start receiving the drug.

---------------------------------------------------------------------

I appologize for any info I have had to skip, but the fax I received
with this info was not of the highest quality. Be assured however
that the source I received it from is a good one, to wit: Medtronics
of Canada. (producers of pacemakers and units for deepbrain
stimulators for Parkinson's patients)

I am glad to be able to share this good news with you.

Regards,

Peter.

 Netmail 1:229/510 (Online Now)
 E-mail: [log in to unmask]